Elizabeth R. Crozier
About Elizabeth R. Crozier
Elizabeth R. Crozier is a financial professional currently serving as Senior Manager of Financial Planning and Analysis at Vertex Pharmaceuticals. She has a background in economics and has held various roles in financial planning and analysis at Wave Life Sciences and CVS Health.
Work at Wave Life Sciences
Elizabeth R. Crozier has been serving as the Manager of Financial Planning and Analysis (FP&A) at Wave Life Sciences since 2022. In this role, she is responsible for overseeing financial planning processes and providing analytical support to enhance decision-making. Prior to her current position, she worked as a Senior Financial Analyst at Wave Life Sciences from 2021 to 2022, where she contributed to financial modeling and reporting initiatives. Her experience at Wave Life Sciences has positioned her to effectively manage financial strategies within the organization.
Education and Expertise
Elizabeth R. Crozier completed her secondary education at Harrison High School, where she earned the International Baccalaureate Diploma. She furthered her education at Boston University, obtaining a Bachelor's Degree in Economics. This academic background provides her with a solid foundation in financial analysis and economic principles, which she applies in her professional roles.
Previous Experience at CVS Health
Before joining Wave Life Sciences, Elizabeth R. Crozier worked as an FP&A Analyst at CVS Health from 2017 to 2019. In this position, she was involved in financial analysis and planning activities that supported the company's financial objectives. Her experience at CVS Health contributed to her expertise in financial management and analysis.
Current Role at Vertex Pharmaceuticals
In 2024, Elizabeth R. Crozier transitioned to Vertex Pharmaceuticals, where she holds the position of Senior Manager in Financial Planning and Analysis. In this role, she continues to leverage her financial expertise to support the company's strategic initiatives. Her experience across various organizations in the biotechnology and healthcare sectors enhances her capability in financial leadership.